1 Biotech Stock to Double Down on in Q4 Leading drug maker Amgen (AMGN) delivered impressive second-quarter results. The company is well-positioned for solid long-term growth, driven by its diversified and growing product portfolio, rising demand from a rapidly… Previous Article Watch the Pitch That Landed a $175,000 Investment Next Article How to Start a Business with Only $1,000
